Cardiovascular Ultrasound Market by Technology (2D, 3D/4D, Doppler), Type ((Trans-Thoracic, Trans-Esophageal, Stress Echocardiogram), Fetal Ultrasound), Display (Color, B/W), End User (Hospitals, Diagnostic Centers, ASCS, Home Care) - Global Forecasts to 2030
The global cardiovascular ultrasound market is projected to reach USD 2.95 billion by 2030 from USD 1.56 billion in 2022, at a CAGR of 6.5% during the forecast period. The growth in the cardiovascular ultrasound market is driven by the rising prevalence of cardiovascular diseases, the integration of AI & digital tools with ultrasound, and increasing research & funding initiatives to develop novel cardiac imaging modalities.
To know about the assumptions considered for the study, Request for Free Sample Report
However, limited reimbursement coverage for related procedures and a shortage of skilled technicians for device operations are some factors expected to restrain market growth to a certain extent.
As of 2022, major players operating in the cardiovascular ultrasound market are GE Healthcare (US), Hitachi Corporation (Japan), Samsung (South Korea), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Chison Medical Technologies (China), Clarius Mobile Health (Canada), Esaote (Italy), Ricso Technology (Israel), and SIUI (China), among others.
Research Methodology
The study involved four major activities in estimating the current size of the cardiovascular ultrasound market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Top-down and bottom-up approaches were employed to estimate the total market size. After that, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments.
Secondary Research
The secondary sources referred to in this research study include corporate filings (such as annual reports, SEC filings, investor presentations, and financial statements); research journals; and press releases; trade, business, and professional associations. Secondary sources were used to identify and collect helpful information for this extensive and commercial study of the cardiovascular ultrasound market. Secondary research was mainly used to obtain critical information about the industry’s total pool of key players, market classification and segmentation according to industry trends to the bottom-most level, market trends, and necessary developments by both the public and private organizations in the cardiovascular ultrasound market.
The secondary sources for this research study include government, independent or public, paid/private, and research databases, among others. Secondary data was collected and analyzed to arrive at the overall market size of the cardiovascular ultrasound market, which was further validated by primary research. Some of the critical secondary sources referred to during the preparation of this report are listed below-
- Governmental and inter-governmental sources & databases such as World Health Organization (WHO), World Bank, Organisation for Economic Co-operation and Development (OECD), and Centers for Disease Control and Prevention (CDC), European Commission, and American Heart Association (AHA), among others.
- Business and research articles such as Springer Nature, The Lancet, PubMed, and the US National Library of Medicine, among others.
- Company sources include annual reports, SEC filings, regulatory filings, investor presentations, press releases, and financial statements.
Primary Research
Extensive primary research was conducted after acquiring knowledge about the cardiovascular ultrasound market scenario through secondary research. A significant number of primary interviews were conducted from both the demand (healthcare providers, diagnostic centers, hospitals, ASC facilities) and supply sides (developers, manufacturers, and distributors of cardiovascular ultrasound products). The primaries interviewed for this study include experts from the diagnostic imaging industry (such as CEOs, VPs, directors, sales heads, and marketing managers of tier 1, 2, and 3 companies engaged in offering cardiovascular ultrasound devices across the globe) and administrators & purchase managers of hospitals and diagnostic centers.
Around 65% and 35% of primary interviews were conducted from the supply and demand sides. A robust primary research methodology has been adopted to validate the report's contents and fill gaps. Telephonic and e-mail communications were adopted to conduct interviews (questionnaires were designed and sent to primary participants at their convenience).
The cardiovascular ultrasound market comprises several stakeholders, such as diagnostic centers, hospitals, and ASC facilities. The demand side of this market is characterized by a growing incidence of cardiovascular diseases, a rapidly increasing geriatric population, and government efforts to cover CVD procedures for reimbursements. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is the breakdown of primary respondents:
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the cardiovascular ultrasound market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and markets have been identified through extensive secondary research
- The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research
- All percentage shares split, and breakdowns have been determined using secondary sources and verified through primary sources
Data Triangulation
After arriving at the overall market size—using the market size estimation processes as explained above—the cardiovascular ultrasound market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the cardiovascular ultrasound industry.
To know about the assumptions considered for the study, download the pdf brochure
Report Objectives
- To define, describe, and forecast the cardiovascular ultrasound market by test type, technology, display type, end user, and region
- To provide detailed information about significant factors influencing the market growth (key drivers, restraints, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets1 concerning individual growth trends, prospects, and their contributions to the overall cardiovascular ultrasound market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the market value of various segments and sub-segments concerning five main regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players active in the cardiovascular ultrasound market and comprehensively analyze their global revenue shares and core competencies2
- To track and analyze competitive market-specific developments such as product approvals & commercialization, agreements, partnerships, collaborations, acquisitions, and expansions in the cardiovascular ultrasound market
Want to explore hidden markets that can drive new revenue in Cardiovascular Ultrasound Market?
Scope of the Report
Want to explore hidden markets that can drive new revenue in Cardiovascular Ultrasound Market?
Report Metric |
Details |
Market Size Available for Years |
2020–2030 |
Base Year Considered |
2021 |
Forecast Period |
2022–2030 |
Forecast Units |
Value (USD) |
Segments Covered |
Type, Technology, Display Type, End User, and Region |
Geographies Covered |
North America (US & Canada), Europe (Germany, UK, France, Italy, Spain, and RoE), APAC (Japan, China, India, Australia, South Korea, and the RoAPAC), LATAM (Brazil, Mexico, and RoLATAM), and MEA |
Companies Covered |
Chison Medical Technologies (China), Clarius Mobile Health (Canada), Dawei Medical (China), Esaote (Italy), GE Healthcare (Us), Hitachi Corporation (Japan), Philips Healthcare (Netherlands), Ricso Technology (Israel), Samsung (South Korea), Shenzhen Lanmage Medical Technology (China), Siemens Healthineers (Germany) SIUI (China), Spectranetics (Us), and Whale Imaging (US), among others |
This research report categorizes the cardiovascular ultrasound market based on Test Type, Technology, Display Type, End User, and region
By Type
- Trans-thoracic Echocardiogram
- Trans-oesophageal Echocardiogram
- Stress Echocardiogram
- Fetal ultrasound
- Other Echocardiograms
By Technology
- 2D ultrasound
- 3D/4D ultrasound
- Doppler ultrasound
By Display Type
- Colour ultrasound
- B/W ultrasound
By End User
- Hospitals and Surgical Centers
- Ambulatory Surgical Centers
- Diagnostic Centers
- Home Care
- Other End Users
By Region
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- RoE
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia and New Zealand
- RoAPAC
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- The Middle East and Africa
Available Customizations
With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for the cardiovascular ultrasound market report:
PRODUCT ANALYSIS
- Product Matrix, which gives a detailed comparison of the product portfolios of the top five global players
PRODUCT ANALYSIS
- Further breakdown of the Rest of Europe cardiovascular ultrasound market into Russia, Portugal, Belgium, Denmark, Switzerland, and other European countries (aggregated)
COMPANY INFORMATION
- Detailed analysis and profiling of additional market players (up to 5 OEMs)
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 RESEARCH SCOPE
1.3.1 MARKETS COVERED
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED FOR THE STUDY
1.5 KEY STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 PRIMARY DATA SOURCES
2.2 SECONDARY DATA SOURCES
2.3 MARKET SIZE ESTIMATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 MARKET DYNAMICS
5.1.1 MAJOR DRIVERS
5.1.2 MAJOR RESTRAINTS
5.1.3 KEY MARKET OPPORTUNITIES
5.1.4 INDUSTRY-SPECIFIC CHALLENGES
5.2 GLOBAL REIMBURSEMENT LANDSCAPE BY PRODUCT/REGION (AS OF 2022)
5.2.1 NORTH AMERICA
5.2.2 EUROPE
5.2.3 ASIA PACIFIC
5.2.4 REST OF WORLD
5.3 AVERAGE SELLING PRICE FOR TARGET PRODUCTS BY REGION (USD, AS OF 2022)
5.3.1 NORTH AMERICA
5.3.2 EUROPE
5.3.3 ASIA PACIFIC
5.3.4 LATIN AMERICA
5.3.5 MIDDLE EAST AND AFRICA
6 CARDIOVASCULAR ULTRASOUND MARKET VALUE DATA, BY TYPE (USD MILLION; 2020-2030) *
6.1 TRANS-THORACIC ECHOCARDIOGRAM
6.2 TRANS-ESOPHAGEAL ECHOCARDIOGRAM
6.3 STRESS ECHOCARDIOGRAM
6.4 FETAL ULTRASOUND
6.5 OTHER ECHOCARDIOGRAMS
7 CARDIOVASCULAR ULTRASOUND MARKET VALUE DATA BY TECHNOLOGY (USD MILLION; 2020-2030) *
7.1 2D ULTRASOUND
7.2 3D/4D ULTRASOUND
7.3 DOPPLER ULTRASOUND
8 CARDIOVASCULAR ULTRASOUND MARKET VALUE DATA BY DISPLAY TYPE (USD MILLION; 2020-2030) *
8.1 COLOUR ULTRASOUND
8.2 B/W ULTRASOUND
9 CARDIOVASCULAR ULTRASOUND MARKET VALUE DATA BY END-USER (USD MILLION; 2020-2030)*
9.1 HOSPITALS AND SURGICAL CENTERS
9.2 AMBULATORY SURGICAL CENTERS
9.3 DIAGNOSTIC CENTERS
9.4 HOME CARE
9.5 OTHER END USERS
10 CARDIOVASCULAR ULTRASOUND MARKET VALUE DATA BY REGION (USD MILLION; 2020-2030)
10.1 NORTH AMERICA
10.1.1 THE US
10.1.2 CANADA
10.2 EUROPE
10.2.1 GERMANY
10.2.2 THE UK
10.2.3 FRANCE
10.2.4 ITALY
10.2.5 SPAIN
10.2.6 REST OF EUROPE
10.3 ASIA-PACIFIC
10.3.1 CHINA
10.3.2 JAPAN
10.3.3 INDIA
10.3.4 SOUTH KOREA
10.3.5 AUSTRALIA AND NEW ZEALAND
10.3.6 REST OF ASIA-PACIFIC
10.4 LATIN AMERICA
10.4.1 BRAZIL
10.4.2 MEXICO
10.4.3 REST OF LATIN AMERICA
10.5 MIDDLE EAST AND AFRICA
11 COMPETITIVE LANDSCAPE
11.1 GLOBAL CARDIOVASCULAR ULTRASOUND MARKET SHARE ANALYSIS BY TOP 3 PLAYERS (IN TERMS OF % REVENUE, 2021)
11.2 COMPETITIVE SCENARIO (2020-2022)
11.3 COMPETITIVE LEADERSHIP MAPPING (FOR 25 MAJOR MARKET PLAYERS AS OF 2022)
113.1 VENDOR INCLUSION CRITERIA
11.3.1.1 PERVASIVE
11.3.1.2 INNOVATORS
11.3.1.3 PARTICIPANTS
11.3.1.4 EMERGING LEADERS
12 COMPANY PROFILES**
(Business Overview, Products Offered, Industry-specific Developments for 2020 - 2022)***
12.1 BIOCARE
12.2 CHISON MEDICAL TECHNOLOGIES
12.3 CLARIUS MOBILE HEALTH
12.4 DAWEI MEDICAL
12.5 ESAOTE
12.6 GE HEALTHCARE
12.7 HITACHI CORPORATION
12.8 MARVOTO TECHNOLOGY
12.9 MEDISONO
12.10 PHILIPS HEALTHCARE
12.11 RICSO TECHNOLOGY
12.12 SAMSUNG
12.13 SHENZHEN LANMAGE MEDICAL TECHNOLOGY
12.14 SIEMENS HEALTHINEERS
12.15 SIFSOF
12.16 SIUI
12.17 SPECTRANETICS
12.18 SUNWAY MEDICAL
12.19 VINNO
12.20 WUXI CANSONIC MEDICAL
13 APPENDIX
NOTE:
* Market segmentation might change slightly based on insights from the actual research study.
**The top 20 global cardiovascular ultrasound market companies shall be profiled; the list will be decided based on insights gathered during the research study.
***Details on business overview, products offered, and industry-specific developments might not be captured in case of unlisted/privately held companies; those that do not provide the above information in the public domain.
Growth opportunities and latent adjacency in Cardiovascular Ultrasound Market